Dubai: At this year’s Arab Health Exhibition and Congress, Clemenceau Medical Center in Dubai Healthcare City (CMC-DHCC) has announced their strategic partnership with Siemens Healthineers, the leading manufacturer of diagnostic and therapeutic imaging and laboratory diagnostics globally.
Clemenceau Medical Center-DHCC, a 110-bed state-of-the-art medical center with the latest available technologies and medical procedures set to augment the overall treatment methodologies and improve patients’ medical experience, is ready to open its doors later this year. CMC-DHCC will constitute one of Clemenceau Medicine Network's main hubs, with the objective of implementing Clemenceau Medicine's established healthcare delivery system to patients in Dubai. Clemenceau Medicine Network, operated by Clemenceau Medicine International (CMI), is an assimilated network of centers of excellence composed of the core hub CMC Beirut, as well as CMC-DHCC and CMC Riyadh (a 180-bed state-of-the-art medical center).
This strategic partnership will increase value by expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalizing healthcare. CMC-DHCC has selected a full solution ranging from innovative diagnostic technologies (MRI 3Tesla, PET/CT, CT scan, and flat panel X-ray systems for women’s health, trauma, and operating rooms) and interventional radiology/cardiology equipment. Moreover, the latest diagnostic and therapeutic software were provided with the equipment to ensure the highest quality of care delivery to the patient.
One of the key benefits of this partnership will be the connectivity to the Hospital Information System (HIS), which is also integrated with Siemens Healthineers’ Picture Archiving and Communication System (PACS) and Cardiovascular Information System (CVIS). This allows for improved efficiency within the hospital, while maintaining high levels of patient care. In addition, all images, procedure reports, and business information are now retained within the same system and are readily available for remote access.
Speaking about the success of the new partnership ahead of this year’s Arab Health Exhibition and Congress, Dr. Mounes Kalaawi, founding CEO of Clemenceau Medical Center (Beirut) and Chairman of Clemenceau Medicine International, stated: “Our network of hospitals integrate the latest technologies and superior modern design, with a deeply rooted ethics of excellent patient care and hospitality services. Through our strategic alliances and partnerships, we extend our reach and accomplish more. Siemens Healthineers has a strong presence in Dubai, and will provide CMC-DHCC with a competitive edge with their continuous support that will maximize opportunities in UAE’s transforming and dynamic healthcare industry.”
In addition to equipping the hospitals with state-of-the-art medical technology, Siemens Healthineers will also be providing technical support, coupled with application training to assist in the continuous education and skill development of medical staff.
“As a technology partner, our goal is to support our customers with holistic solutions for complex challenges in the hospital environment. We are very pleased to enter this alliance with Clemenceau Medical Center, a leading name in the industry, and we are very confident that with our products, solutions and their skilled specialists, we create a winning pair that will together deliver high-value care to support more patients in the UAE”, commented Ole Per Maloy, Managing Director, Siemens Healthineers, Middle East and Southern and Eastern Africa.
Clemenceau Medical Center in Dubai Healthcare City is expected to open June 2019.
About Siemens Healthineers
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.
In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide. Further information is available at www.siemens-healthineers.com.
About Clemenceau Medical Center
Clemenceau Medical Center (CMC) is a medical center affiliated with Johns Hopkins Medicine International located in Beirut, Lebanon. CMC has received multiple accreditations from Joint Commission International and has also achieved several certification for excellence in quality of care and services. The Joint Commission International (JCI)-accredited Center in Beirut was recognized as one of the top 10 hospitals globally for medical travel by independent international organization. Clemenceau is a well-known name and its patient demographic is representative of, GCC and the MENA region, in addition to Lebanese expatriates living in the US and Europe. Further information is available at www.cmc.com.lb.
About Clemenceau Medicine International
Clemenceau Medicine International (CMI) provides all the technical assistance services needed to establish and operate a state-of-the-art healthcare facility, Through CMI, the Clemenceau Medicine Network extends from Clemenceau Medical Center in Beirut (CMC Beirut) to the upcoming medical centers in Dubai (CMC-DHCC), Riyadh (CMC Riyadh) and in the near future to other cities in the region. Further information is available at www.clemenceaumedicine.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
